Cero Therapeutics Holdings (CERO) Net Income (2022 - 2026)
Cero Therapeutics Holdings (CERO) reported Net Income of -$4.54 million for Q2 2026, compared with -$4.71 million a year earlier.
Powered by 
Analysis
Cero Therapeutics Holdings (CERO) Net Income (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cero Therapeutics Holdings' Net Income came in at -$18.33 million; for FY2025, it came in at -$18.46 million.
- By year, Net Income came in at -$15.28 million in FY2024, -$2.54 million in FY2023, -$667,736 in FY2022 and -$315,547 in FY2021.
- Five-year quarterly Net Income spans a low of -$5.17 million in Q2 2024 and a high of $84,505 in Q3 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$5.01 million (Q1 2026), -$4.43 million (Q4 2025) and -$4.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,126.20 Bn | 1,094.78 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 633.36 Bn | 553.22 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 504.51 Bn | 477.62 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 357.58 Bn | 311.96 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 289.65 Bn | 253.64 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 264.97 Bn | 238.66 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.69 Bn | 193.09 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.48 Bn | 168.68 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Cero Therapeutics Holdings | 172,917.58 | -5.31 Mn | - | -1.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.03 Mn |
| Mar 31, 2026 | -5.89 Mn |
| Dec 31, 2025 | -4.54 Mn |
| Sep 30, 2025 | -4.86 Mn |
| Jun 30, 2025 | -5.42 Mn |
| Mar 31, 2025 | -5.11 Mn |
| Dec 31, 2024 | 671,892.00 |
| Sep 30, 2024 | -4.23 Mn |
| Jun 30, 2024 | -2.45 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -1.27 Mn |
| Sep 30, 2023 | -1.35 Mn |
| Jun 30, 2023 | -2.09 Mn |
| Mar 31, 2023 | -2.44 Mn |
| Dec 31, 2022 | -262,675.00 |
| Sep 30, 2022 | 84,505.00 |
| Jun 30, 2022 | -111,569.00 |
| Mar 31, 2022 | -377,997.00 |
API Access
Cero Therapeutics Holdings Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=CERO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "CERO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=CERO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();